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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   














 An overview, of 
the most recently 
available data 
about SARS-CoV-







strategies and the 
associated 
COVID-19 risk 
and the potential 
of 
immunotherapies 























 Non-random testing and 
incomplete vital registration 
systems challenge 
estimating directly the 
infection fatality rate (IFR) 
in many LMICs 
 This paper estimates the 
adjustments required to 
extrapolate estimates of 
IFR from high- to lower-
income regions 
 Predicted IFR across 21 
world regions range from 
0.11% in Western sub-
Saharan Africa to 1.07% 
for high-income Asia 
Pacific when accounting 
for differences in the 
distribution of age, sex, 
and relevant comorbidities 
 Adjusting for health system 
capacity greatly 
diminishes, but does not 
erase entirely, the 
demography-based 
advantage predicted from 
the lowest income settings 


















 The impact of contact 
clustering in social 
bubbles, as part of gradual 
lockdown exit strategy, on 
epidemic and mortality risk 
was estimated using the 
UK as a case study 
 Analysis highlights the 
continued need for social 
distancing despite a social 
bubble strategy being 
effective in expanding 
contacts while limited the 
risk for a resurgence of 
cases.  
 Recommending social 
bubbles only for those 
struggling with lockdown 
alongside continuing 






for gathers and maintaining 
social distancing could 
strike a balance between 
minimising the impact on 
mental health and 
minimising the C19 
epidemic risk 






















 Analysis combines data 
on demography, contact 
patterns, disease severity 
and health care capacity 
and quality to understand 
its impact and inform 
strategies for its control 
 Limited health system 
capacity and closer inter-
generational contact 
negate the “benefit” of 
younger populations in 
LICs 
 Mitigation strategies that 
slow but do not interrupt 
transmission will still 
result in health systems 
being overwhelmed due 
to the poorer health care 
available 
 Many lower income 
countries acted quickly 
when transmission was 
low which likely 
substantially slowed viral 
spread 
 This will need to be 
maintained or triggered 
frequently to keep within 
























 Retrospective systematic 
screening of all 
cerebrospinal fluid (CSF) 
samples (n=622) at 
University Hospital in Lyon, 
France 1 Feb to 11 May 
2020 
 SARS-CoV-2 detection in 
CSF samples was very low 
suggesting that although 
SARS-CoV-2 can replicate 
in neuronal cells in vitro, 
SARS-CoV-2 testing in 
CSF is currently not 
relevant in the general 
population 
 Further studies are required 
to identify the potential role 
of the host-immune 
response on neurological 












 This study recommends 
pooling of 4 in 1 using the 
standard protocols of the 
assay, reagents and 
equipment, expected to 
retain test accuracy 
 This approach allows 




12.06.2020 An imperfect 
tool: COVID-












 medRxiv | 
Preprint (not 
peer reviewed) 
 Although this study extends 
an existing UK-focused 
branching process model, it 
highlights that test accuracy 
must be considered when 
relaxing physical distancing 










Summary             Keywords 
11.06.2020 Hydroxychloroquin
e proves ineffective 







 Although many human 




c use of 
hydroxychloroquine 
(HCQ) for C19 there 
remains a lack of 
supportive preclinical 
drug efficacy studies 
 This preclinical animal 
study in two animal 
models does not 






Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
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Author(s) 




13.06.2020 Offline: COVID-19 - what can we expect 
to come 
The Lancet | 
Comment 
Richard Horton 
12.06.2020 Predicting COVID-19 infection fatality 
rates around the world 




Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
 10.06.2020 COVID-19 
measures must be 
grounded first and 
foremost on the 




 UN Human Rights Special 
Rapporteur press release on the 
right to health foundation of the 
C19 response 
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 


















  US  COVID-19 
Primer 




     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
  
8 
C19 Resource Hubs 







Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 







  IDA 












































Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 blog 
series 













Institute of Public 
Health 









Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
      














WorldPop           
Flowminder           





    
  
Online learning & events 









Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 




Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
          
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 






















Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 




5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





























the Novel Coronavirus 
Online 
learning 




































of Edinburgh & Royal 
College of Physicians 














Millington, K.A. and Reddin, S. (2020). COVID-19 Health Evidence Summary No.61. K4D 
Evidence Summary. Brighton, UK: Institute of Development Studies. 
Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
